These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8410631)

  • 21. New developments in cosmetics and skin care products.
    Draelos ZD
    Adv Dermatol; 1997; 12():3-17; discussion 18. PubMed ID: 8973733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urea and the skin].
    Wohlrab W
    Schweiz Rundsch Med Prax; 1986 Feb; 75(8):201-4. PubMed ID: 3726375
    [No Abstract]   [Full Text] [Related]  

  • 23. Advances in topical therapy for skin diseases.
    Willsteed EM
    Med J Aust; 1996 Sep; 165(5):274-9. PubMed ID: 8816688
    [No Abstract]   [Full Text] [Related]  

  • 24. [Extemporaneous formulas from the viewpoint of dermatology. Obsolete or up-to-date?].
    Staubach P
    Pharm Unserer Zeit; 2010 Jul; 39(4):288-92. PubMed ID: 20589801
    [No Abstract]   [Full Text] [Related]  

  • 25. New and emerging treatments in dermatology: acne.
    Katsambas A; Dessinioti C
    Dermatol Ther; 2008; 21(2):86-95. PubMed ID: 18394082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The critical role of the vehicle to therapeutic efficacy and patient compliance.
    Piacquadio D; Kligman A
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 3):S67-73. PubMed ID: 9703127
    [No Abstract]   [Full Text] [Related]  

  • 27. Liposomes.
    Posner R
    J Drugs Dermatol; 2002 Sep; 1(2):161-4. PubMed ID: 12847740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prescribe topical treatments for psoriasis].
    Lorette G; Fontès V
    Rev Prat; 2004 Jan; 54(1):40-2. PubMed ID: 15049598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reply: hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin.
    Chandrashekar L
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1348-9. PubMed ID: 17062068
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of the performances of Unguator mixing equipments for the pharmaceutical compounding of dermatological dosage forms].
    Stassen T; Piette M; Kinget R; Delattre L
    J Pharm Belg; 2006; 61(1):1-10. PubMed ID: 16669341
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Percutaneous absorption: topical and systemic treatments].
    Machet L; Baïcan A; Pelucio-Lopes C; Patat F; Vaillant L
    Ann Dermatol Venereol; 1997; 124(6-7):490-6. PubMed ID: 9739917
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of bioavailability by lowering of fat content in topical formulations.
    Wirén K; Frithiof H; Sjöqvist C; Lodén M
    Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [External agents for the care and treatment of the skin].
    Fröhlich HH
    Pharm Unserer Zeit; 1979 Nov; 8(6):179-88. PubMed ID: 538049
    [No Abstract]   [Full Text] [Related]  

  • 36. [Skin protection in the factory].
    Münich M
    Fortschr Med; 1976 May; 94(14):791-2. PubMed ID: 131778
    [No Abstract]   [Full Text] [Related]  

  • 37. Understanding generics.
    Kircik LH
    J Drugs Dermatol; 2014 Jul; 13(7):s75-6. PubMed ID: 25007375
    [No Abstract]   [Full Text] [Related]  

  • 38. [Local and transcutaneous pharmacotherapy. Pharmacokinetic principles and clinical evaluation].
    Stüttgen G; Täuber U; Bauer E; Zesch A
    Hautarzt; 1986 Feb; 37(2):65-76. PubMed ID: 3957664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents.
    Krejci-Manwaring J; McCarty MA; Camacho F; Carroll CL; Johnson K; Manuel J; Balkrishnan R; Hartle J; Fleischer A; Feldman SR
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S235-6. PubMed ID: 16631951
    [No Abstract]   [Full Text] [Related]  

  • 40. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.